ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1982

An Integrative Rheumatoid Arthritis Network for Elucidating Molecular Mechanisms Underlying RA Severity

Wenhui Wang1, Teresina Laragione2, Amit Lahiri2, Jun Zhu1 and Percio S. Gulko3, 1Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, 2Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 3Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: pathogenesis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a pathologically heterogeneous disease with multiple contributing factors. Many models have been developed to study RA severity and progression, and several RA severity signatures have been derived. However, the molecular mechanisms underlying these RA severity signatures are not fully understood. For example, Cia25 congenic rat interval regulates arthritis severity. The congenic region is conserved among mouse, rat, and human. However, which gene or genes in the congenic region regulate RA severity and which molecular mechanisms remains incompletely understood. We recently developed a human molecular causal network for RA. We leveraged the RA network to elucidate potential molecular mechanisms that drive RA severity.

Methods: A gene expression signature comparing Cia25 congenic and parental strains was collected. A candidate gene list including HIP1 was derived by comparative genomic analysis of mouse, rat, and human genome and comparing SNPs between Cia25 congenic and parental strains.

Results: Cia25 congenic signature was projected to the human RA network that we constructed. We derived a Cia25 congenic subnetwork by using the signature as seeds and collecting nodes that were within 2 hops from the seeds. We compared the subnetwork with GO biological pathways, and found genes involved in immune response, cell adhesion, and cell migration pathways were significantly enriched in the subnetwork. We further compared transcription factor (TF) binding sites in promoter regions of genes in the subnetwork and known TF binding motifs, and found binding sites for transcription factors BACH1 and BACH2 were enriched in the subnetwork. Bach1 has been shown to regulate osteoclast in mouse models. BACH2 was identified a GWAS as a candidate gene for RA susceptibility. It is worth to note that one of the candidate genes for the Cia25 congenic strain is HIP1. In the RA network, HIP1 was regulated by STK3 and STK3 was a part of Cia25 congenic subnetwork. The HIP1 subnetwork (including genes that can be reached from HIP1 within 3 hops) significantly overlapped with the Cia25 congenic subnetwork, supporting HIP1 as a potential candidate for Cia25 congenic strain. For proof of concept we knockdown HIP1 in human fibroblast-like synoviocytes and detected significantly reduced cell invasiveness.

Conclusion: We used a new RA synovial gene network to help identify new arthritis regulatory genes by integrating complex datasets and show that this strategy led to validation and discovery of new arthritis susceptibility and severity genes.


Disclosure: W. Wang, None; T. Laragione, None; A. Lahiri, None; J. Zhu, None; P. S. Gulko, None.

To cite this abstract in AMA style:

Wang W, Laragione T, Lahiri A, Zhu J, Gulko PS. An Integrative Rheumatoid Arthritis Network for Elucidating Molecular Mechanisms Underlying RA Severity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/an-integrative-rheumatoid-arthritis-network-for-elucidating-molecular-mechanisms-underlying-ra-severity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-integrative-rheumatoid-arthritis-network-for-elucidating-molecular-mechanisms-underlying-ra-severity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology